Literature DB >> 28889326

Myocardial contractile patterns predict future cardiac events in sarcoidosis.

Jian Chen1,2, Juan Lei1,3, Ernest Scalzetti4, Mary McGrath4, David Feiglin4, Robert Voelker1, Jingfeng Wang3, Michael C Iannuzzi5, Kan Liu6.   

Abstract

The poor prognosis of cardiac sarcoidosis (CS) underscores the need for risk stratification. We evaluated 84 consecutive sarcoidosis patients who were referred for echocardiographic studies for cardiac symptoms or abnormal electrocardiograms. In 54 patients without previous diagnosis of CS or other known structural heart disease, 13 reached endpoints during (median) 24 months follow up. Significantly impaired peak systolic longitudinal strain in their original echocardiograms were identified in 13 of 17 left ventricular segments, clustering in the free wall, interventricular septum and apex. The regional (including 13 clustered segments) peak systolic longitudinal strain (RPSLS) were significantly impaired in patients with endpoints, compared with those without [(-11.4 ± 4.45) vs. (-18.7 ± 3.76) %, P < 0.00001]. Cox multivariate regression analysis revealed that RPSLS was independently associated with endpoints (HR 1.24; 95% CI 1.08-1.42, P = 0.002). Receiver operating characteristic curve suggested a cut-off RPSLS value of -15.0% (84.6% sensitivity and 86.8% specificity) to predict the occurrence of endpoints. Impaired RPSLS correlates with risk of adverse cardiac events in patients with extra-cardiac sarcoidosis.

Entities:  

Keywords:  Cardiac sarcoidosis; Regional peak systolic longitudinal strain; Risk stratification

Mesh:

Year:  2017        PMID: 28889326     DOI: 10.1007/s10554-017-1233-9

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  41 in total

Review 1.  Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment.

Authors:  George Youssef; Rob S B Beanlands; David H Birnie; Pablo B Nery
Journal:  Heart       Date:  2011-12       Impact factor: 5.994

Review 2.  Role of tissue Doppler and strain echocardiography in current clinical practice.

Authors:  Theodore P Abraham; Veronica L Dimaano; Hsin-Yueh Liang
Journal:  Circulation       Date:  2007-11-27       Impact factor: 29.690

Review 3.  Sarcoidosis.

Authors:  Michael C Iannuzzi; Benjamin A Rybicki; Alvin S Teirstein
Journal:  N Engl J Med       Date:  2007-11-22       Impact factor: 91.245

Review 4.  Recommendations for the evaluation of left ventricular diastolic function by echocardiography.

Authors:  Sherif F Nagueh; Christopher P Appleton; Thierry C Gillebert; Paolo N Marino; Jae K Oh; Otto A Smiseth; Alan D Waggoner; Frank A Flachskampf; Patricia A Pellikka; Arturo Evangelista
Journal:  J Am Soc Echocardiogr       Date:  2009-02       Impact factor: 5.251

5.  Myocardial sarcoidosis in forensic medicine.

Authors:  T K Thomsen; T Eriksson
Journal:  Am J Forensic Med Pathol       Date:  1999-03       Impact factor: 0.921

Review 6.  Pathophysiology and clinical management of cardiac sarcoidosis.

Authors:  Nabeel Hamzeh; David A Steckman; William H Sauer; Marc A Judson
Journal:  Nat Rev Cardiol       Date:  2015-02-24       Impact factor: 32.419

7.  Longitudinal and circumferential strain rate, left ventricular remodeling, and prognosis after myocardial infarction.

Authors:  Chung-Lieh Hung; Anil Verma; Hajime Uno; Sung-Hee Shin; Mikhail Bourgoun; Amira H Hassanein; John J McMurray; Eric J Velazquez; Lars Kober; Marc A Pfeffer; Scott D Solomon
Journal:  J Am Coll Cardiol       Date:  2010-11-23       Impact factor: 24.094

8.  High resolution speckle tracking dobutamine stress echocardiography reveals heterogeneous responses in different myocardial layers: implication for viability assessments.

Authors:  Assami Rösner; Ole Jakob How; Erling Aarsaether; Thor Allan Stenberg; Thomas Andreasen; Timofei V Kondratiev; Terje S Larsen; Truls Myrmel
Journal:  J Am Soc Echocardiogr       Date:  2010-04       Impact factor: 5.251

9.  Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease.

Authors:  D Valeyre; P Soler; C Clerici; J Pré; J P Battesti; R Georges; A J Hance
Journal:  Thorax       Date:  1988-07       Impact factor: 9.139

10.  Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.

Authors:  Ron Blankstein; Michael Osborne; Masanao Naya; Alfonso Waller; Chun K Kim; Venkatesh L Murthy; Pedram Kazemian; Raymond Y Kwong; Michifumi Tokuda; Hicham Skali; Robert Padera; Jon Hainer; William G Stevenson; Sharmila Dorbala; Marcelo F Di Carli
Journal:  J Am Coll Cardiol       Date:  2013-10-16       Impact factor: 24.094

View more
  2 in total

1.  Predicting adverse cardiac events in sarcoidosis: deep learning from automated characterization of regional myocardial remodeling.

Authors:  Chenying Lu; Yi Grace Wang; Fahim Zaman; Xiaodong Wu; Mehul Adhaduk; Amanda Chang; Jiansong Ji; Tiemin Wei; Promporn Suksaranjit; Georgios Christodoulidis; Ernest Scalzetti; Yuchi Han; David Feiglin; Kan Liu
Journal:  Int J Cardiovasc Imaging       Date:  2022-02-22       Impact factor: 2.357

Review 2.  Sarcoidosis: Pitfalls and Challenging Mimickers.

Authors:  Naureen Narula; Michael Iannuzzi
Journal:  Front Med (Lausanne)       Date:  2021-01-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.